Related Experiment Video
Updated: Jun 8, 2026
10:32
Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Disability in leprosy patients after MDT.
1Departments of PSM, Institute of Medical Sciences, BHU, Varanasi-221001, India.
Indian Journal of Dermatology, Venereology and Leprology
|October 16, 2010
Summary
Dapsone monotherapy can worsen disabilities. Multidrug therapy (MDT) showed an increase in severe disabilities, highlighting the need for regular disability checks and prompt MDT initiation to prevent worsening leprosy outcomes.
Area of Science:
- Medical Research
- Public Health
- Leprosy Studies
Background:
- Dapsone monotherapy is associated with progressive disabilities in leprosy patients.
- Leprosy management strategies aim to prevent and reduce disability.
- The National Leprosy Eradication Programme (NLEP) utilizes multidrug therapy (MDT).
Purpose of the Study:
- To evaluate the impact of multidrug therapy (MDT) on disability progression in leprosy patients.
- To identify factors contributing to disability during leprosy treatment.
Main Methods:
- A study was conducted in the Chiraigaon block involving patients who completed MDT under NLEP.
- Patient interviews were conducted to gather data on disability status.
- Analysis focused on disability grading (Grade II and III) during MDT.
Main Results:
- A significant increase in Grade II and III disabilities was observed during MDT.
- Delayed initiation of MDT after disease onset was a key factor in high disability rates.
- Regular disability examinations were not consistently performed.
Conclusions:
- MDT alone did not prevent disability progression in the observed cohort.
- Timely disability assessment and prompt MDT initiation are crucial for mitigating leprosy-related disabilities.
- The findings underscore the importance of integrated care within leprosy control programs.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.